Age-Specific Changes in Intrinsic Breast Cancer Subtypes: A Focus on Older Women
Open accessThe DOI matches its Crossref record; 41 of the 42 references it cites were found in a registry or an index.
Abstract
Purpose.: Breast cancer (BC) is a disease of aging and the number of older BC patients in the U.S. is rising. Immunohistochemical data show that with increasing age, the incidence of hormone receptor-positive tumors increases, whereas the incidence of triple-negative tumors decreases. Few data exist on the frequency of molecular subtypes in older women. Here, we characterize the incidence and outcomes of BC patients by molecular subtypes and age. Patients and Methods.: Data from 3,947 patients were pooled from publicly available clinical and gene expression microarray data sets. The PAM50 algorithm was used to classify tumors into five BC intrinsic subtypes: luminal A, luminal B, HER2-enriched, basal-like, and normal-like. The association of age and subtype with recurrence-free survival (RFS), overall survival, and disease-specific survival (DSS) was assessed. Results.: The incidence of luminal (A, B, and A+B) tumors increased with age (p < .01, p < .0001, and p < .0001, respectively), whereas the percentage of basal-like tumors decreased (p < .0001). Among patients 70 years and older, luminal B, HER2-enriched, and basal-like tumors were found at a frequency of 32%, 11%, and 9%, respectively. In older women, luminal subtypes had better outcomes than basal-like and HER2-enriched subtypes. After controlling for subtype, treatment, tumor size, nodal status, and grade, increasing age had no impact on RFS or DSS. Conclusion.: More favorable BC subtypes increase with age, but older patients still have a substantial percentage of high-risk tumor subtypes. After accounting for tumor subtypes, age at diagnosis is not an independent prognostic factor for outcome.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“ER-positive breast cancer incidence increases with age (199).”
From Metabolic impact of endogenously produced estrogens by adipose tissue in females and males across the lifespan (2025) · cites this paper as [199]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Comprehensive molecular portraits of human breast tumours
The Cancer Genome Atlas Network (2012) · Nature · doi:10.1038/nature11412 · Cited by 12,129
SEER Cancer Statistics Review, 1975-2003
Ries, L. A. G., Harkins, D., Krapcho, M. F., Mariotto, A. B., Miller, B., Feuer, E. J., Clegg, L. X., Eisner, M. P., Horner, M., Howlader, N., et al. (2006) · Digital Archive @ GSU · Cited by 11,783
The genomic and transcriptomic architecture of 2,000 breast tumours reveals novel subgroups
METABRIC Group, Curtis, C., Shah, S. P., Chin, S.-F., Turashvili, G., Rueda, O. M., Dunning, M. J., Speed, D., Lynch, A. G., Samarajiwa, S., et al. (2012) · Nature · doi:10.1038/nature10983 · Cited by 6,097
Supervised Risk Predictor of Breast Cancer Based on Intrinsic Subtypes
Parker, J. S., Mullins, M., Cheang, M. C. U., Leung, S., Voduc, D., Vickery, T., Davies, S., Fauron, C., He, X., Hu, Z., et al. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.18.1370 · Cited by 4,721
Self-citationGenes that mediate breast cancer metastasis to lung
Minn, A. J., Gupta, G. P., Siegel, P. M., Bos, P. D., Shu, W., Giri, D. D., Viale, A., Olshen, A. B., Gerald, W. L., & Massagué, J. (2005) · Nature · doi:10.1038/nature03799 · Cited by 2,922
Gene-expression profiles to predict distant metastasis of lymph-node-negative primary breast cancer
Wang, Y., Klijn, J. G., Zhang, Y., Sieuwerts, A. M., Look, M. P., Yang, F., Talantov, D., Timmermans, M., Meijer-van Gelder, M. E., Yu, J., et al. (2005) · The Lancet · doi:10.1016/s0140-6736(05)17947-1 · Cited by 2,846
Paik, S., Tang, G., Shak, S., Kim, C., Baker, J., Kim, W., Cronin, M., Baehner, F. L., Watson, D., Bryant, J., et al. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2005.04.7985 · Cited by 2,579
Phenotypic and molecular characterization of the claudin-low intrinsic subtype of breast cancer
Prat, A., Parker, J. S., Karginova, O., Fan, C., Livasy, C., Herschkowitz, J. I., He, X., & Perou, C. M. (2010) · Breast Cancer Research · doi:10.1186/bcr2635 · Cited by 2,167
Self-citationSotiriou, C., Wirapati, P., Loi, S., Harris, A., Fox, S., Smeds, J., Nordgren, H., Farmer, P., Praz, V., Haibe-Kains, B., et al. (2006) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djj052 · Cited by 2,063
Deconstructing the molecular portraits of breast cancer
Prat, A., & Perou, C. M. (2011) · Molecular Oncology · doi:10.1016/j.molonc.2010.11.003 · Cited by 1,343
Self-citationCheang, M. C. U., Voduc, D., Bajdik, C., Leung, S., McKinney, S., Chia, S. K., Perou, C. M., & Nielsen, T. O. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-1658 · Cited by 1,195
Self-citationParticipation of Patients 65 Years of Age or Older in Cancer Clinical Trials
Lewis, J. H., Kilgore, M. L., Goldman, D. P., Trimble, E. L., Kaplan, R., Montello, M. J., Housman, M. G., & Escarce, J. J. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.08.010 · Cited by 1,031
Whole-genome analysis informs breast cancer response to aromatase inhibition
Ellis, M. J., Ding, L., Shen, D., Luo, J., Suman, V. J., Wallis, J. W., Van Tine, B. A., Hoog, J., Goiffon, R. J., Goldstein, T. C., et al. (2012) · Nature · doi:10.1038/nature11143 · Cited by 1,023
Cancer Screening in Elderly Patients: A Framework for Individualized Decision Making
Walter, L. C., & Covinsky, K. E. (2001) · JAMA · doi:10.1001/jama.285.21.2750 · Cited by 1,003
Anders, C. K., Hsu, D. S., Broadwater, G., Acharya, C. R., Foekens, J. A., Zhang, Y., Wang, Y., Marcom, P. K., Marks, J. R., Febbo, P. G., et al. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.14.2471 · Cited by 911
Self-citationNielsen, T. O., Parker, J. S., Leung, S., Voduc, D., Ebbert, M., Vickery, T., Davies, S. R., Snider, J., Stijleman, I. J., Reed, J., et al. (2010) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-10-1282 · Cited by 801
Self-citationGenetic Reclassification of Histologic Grade Delineates New Clinical Subtypes of Breast Cancer
Ivshina, A. V., George, J., Senko, O., Mow, B., Putti, T. C., Smeds, J., Lindahl, T., Pawitan, Y., Hall, P., Nordgren, H., et al. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-4414 · Cited by 752
Prognostic Indices for Older Adults: A Systematic Review
Yourman, L. C., Lee, S. J., Schonberg, M. A., Widera, E. W., & Smith, A. K. (2012) · JAMA · doi:10.1001/jama.2011.1966 · Cited by 736
Hatzis, C. (2011) · JAMA · doi:10.1001/jama.2011.593 · Cited by 699
Tumor Characteristics and Clinical Outcome of Elderly Women With Breast Cancer
Diab, S. G. (2000) · Journal of the National Cancer Institute · doi:10.1093/jnci/92.7.550 · Cited by 674
Dowsett, M., Sestak, I., Lopez-Knowles, E., Sidhu, K., Dunbier, A. K., Cowens, J. W., Ferree, S., Storhoff, J., Schaper, C., & Cuzick, J. (2013) · Journal of Clinical Oncology · doi:10.1200/jco.2012.46.1558 · Cited by 621
Prat, A., Cheang, M. C. U., Martín, M., Parker, J. S., Carrasco, E., Caballero, R., Tyldesley, S., Gelmon, K., Bernard, P. S., Nielsen, T. O., et al. (2013) · Journal of Clinical Oncology · doi:10.1200/jco.2012.43.4134 · Cited by 587
Self-citationEllis, M. J., Suman, V. J., Hoog, J., Lin, L., Snider, J., Prat, A., Parker, J. S., Luo, J., DeSchryver, K., Allred, D. C., et al. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2010.31.6950 · Cited by 551
Self-citationAdjuvant Chemotherapy in Older and Younger Women With Lymph Node–Positive Breast Cancer
Muss, H. B. (2005) · JAMA · doi:10.1001/jama.293.9.1073 · Cited by 418
Self-citationThe I-SPY 1 TRIAL Investigators, Esserman, L. J., Berry, D. A., Cheang, M. C. U., Yau, C., Perou, C. M., Carey, L., DeMichele, A., Gray, J. W., Conway-Dorsey, K., et al. (2012) · Breast Cancer Research and Treatment · doi:10.1007/s10549-011-1895-2 · Cited by 362
Self-citationPAM50 Breast Cancer Subtyping by RT-qPCR and Concordance with Standard Clinical Molecular Markers
Bastien, R. R., Rodríguez-Lescure, Á., Ebbert, M. T., Prat, A., Munárriz, B., Rowe, L., Miller, P., Ruiz-Borrego, M., Anderson, D., Lyons, B., et al. (2012) · BMC Medical Genomics · doi:10.1186/1755-8794-5-44 · Cited by 334
Self-citationBuffa, F. M., Camps, C., Winchester, L., Snell, C. E., Gee, H. E., Sheldon, H., Taylor, M., Harris, A. L., & Ragoussis, J. (2011) · Cancer Research · doi:10.1158/0008-5472.can-11-0489 · Cited by 308
Anders, C. K., Fan, C., Parker, J. S., Carey, L. A., Blackwell, K. L., Klauber-DeMore, N., & Perou, C. M. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2010.28.9199 · Cited by 263
Self-citationPrat, A., Bianchini, G., Thomas, M., Belousov, A., Cheang, M. C. U., Koehler, A., Gómez, P., Semiglazov, V., Eiermann, W., Tjulandin, S., et al. (2014) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-13-0239 · Cited by 229
Self-citationPrat, A., Parker, J. S., Fan, C., & Perou, C. M. (2012) · Breast Cancer Research and Treatment · doi:10.1007/s10549-012-2143-0 · Cited by 194
Self-citationIhemelandu, C. U., Leffall, L. D., Dewitty, R. L., Naab, T. J., Mezghebe, H. M., Makambi, K. H., Adams-Campbell, L., & Frederick, W. A. (2007) · Journal of Surgical Research · doi:10.1016/j.jss.2007.03.085 · Cited by 159
Clinical implementation of the intrinsic subtypes of breast cancer
Perou, C. M., Parker, J. S., Prat, A., Ellis, M. J., & Bernard, P. S. (2010) · The Lancet Oncology · doi:10.1016/s1470-2045(10)70176-5 · Cited by 109
Self-citationAge-Specific Differences in Oncogenic Pathway Deregulation Seen in Human Breast Tumors
Anders, C. K., Acharya, C. R., Hsu, D. S., Broadwater, G., Garman, K. S., Foekens, J. A., Zhang, Y., Wang, Y., Marcom, K., Marks, J. R., et al. (2008) · PLoS ONE · doi:10.1371/journal.pone.0001373 · Cited by 106
Self-citationPAM50 proliferation score as a predictor of weekly paclitaxel benefit in breast cancer
Martín, M., Prat, A., Rodríguez-Lescure, Á., Caballero, R., Ebbert, M., Munárriz, B., Ruíz-Borrego, M., Bastien, R. R. L., Crespo, C., Davis, C. A., et al. (2013) · Breast Cancer Research and Treatment · doi:10.1007/s10549-013-2416-2 · Cited by 103
Self-citationTumour biomarker expression relative to age and molecular subtypes of invasive breast cancer
Morrison, D. H., Rahardja, D., King, E., Peng, Y. S., & Sarode, V. R. (2012) · British Journal of Cancer · doi:10.1038/bjc.2012.219 · Cited by 99
Long-term impact of the 70-gene signature on breast cancer outcome
Drukker, C. A., van Tinteren, H., Schmidt, M. K., Rutgers, E. J. T., Bernards, R., van de Vijver, M. J., & Veer, L. J. V. (2014) · Breast Cancer Research and Treatment · doi:10.1007/s10549-013-2831-4 · Cited by 65
Ring, A. E., Šestak, I., Baum, M., Howell, A., Buzdar, A. U., Dowsett, M., Forbes, J., & Cuzick, J. M. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2011.35.5545 · Cited by 62
Association between breast cancer subtypes and response to neoadjuvant anastrozole
Dunbier, A. K., Anderson, H., Ghazoui, Z. F., Salter, J., Parker, J. S., Perou, C. M., Smith, I. E., & Dowsett, M. (2011) · Steroids · doi:10.1016/j.steroids.2011.02.025 · Cited by 60
Self-citationDurbecq, V., Ameye, L., Veys, I., Paesmans, M., Desmedt, C., Sirtaine, N., Sotiriou, C. P., Bernard-Marty, C., Nogaret, J., Piccart, M. J., et al. (2008) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2007.12.008 · Cited by 58
Eribulin Monotherapy in Patients Aged 70 Years and Older With Metastatic Breast Cancer
Muss, H. B., Cortés, J., Vahdat, L. T., Cardoso, F., Twelves, C., Wanders, J., Dutcus, C. E., Yang, J., Seegobin, S., & O’Shaughnessy, J. (2014) · The Oncologist · doi:10.1634/theoncologist.2013-0282 · Cited by 48
Self-citationAdjuvant therapy of breast cancer in women 70 years of age and older: tough decisions, high stakes.
Jones, E. L., Leak, A., & Muss, H. B. (2012) · PubMed · Cited by 18
Self-citation
Cited by
Effects of Age on the Detection and Management of Breast Cancer
McGuire, A., Brown, J., Malone, C., McLaughlin, R., & Kerin, M. (2015) · Cancers · doi:10.3390/cancers7020815 · Cited by 374
“patients [50,51,85–87] and tend to have better outcomes than the other subtypes [51,85,88,89].”
BackgroundAging-Associated Alterations in Mammary Epithelia and Stroma Revealed by Single-Cell RNA Sequencing
Li, C. M.-C., Shapiro, H., Tsiobikas, C., Selfors, L. M., Chen, H., Rosenbluth, J., Moore, K., Gupta, K. P., Gray, G. K., Oren, Y., et al. (2020) · Cell Reports · doi:10.1016/j.celrep.2020.108566 · Cited by 184
“Moreover, given that increased age is strongly associated with breast cancer susceptibility in human and mouse models (Jenkins et al., 2014; LaBarge et al., 2016; Raafat et al., 2012), a single-cell atlas for aged mammary glands could help fill the gaps in our knowledge of aging and cancer risk.”
Is cancer biology different in older patients?
Van Herck, Y., Feyaerts, A., Alibhai, S., Papamichael, D., Decoster, L., Lambrechts, Y., Pinchuk, M., Bechter, O., Herrera-Caceres, J., Bibeau, F., et al. (2021) · The Lancet Healthy Longevity · doi:10.1016/s2666-7568(21)00179-3 · Cited by 161
Rugo, H. S., Tolaney, S. M., Loirat, D., Punie, K., Bardia, A., Hurvitz, S. A., O’Shaughnessy, J., Cortés, J., Diéras, V., Carey, L. A., et al. (2022) · npj Breast Cancer · doi:10.1038/s41523-022-00467-1 · Cited by 114
“Thrombocytopenia(7) 3 (3) 0 6 (6) 0 4 (12) 4 (12)”
Self-citationThe prognostic impact of age in different molecular subtypes of breast cancer
Liedtke, C., Rody, A., Gluz, O., Baumann, K., Beyer, D. A., Kohls, E.-B., Lausen, K., Hanker, L., Holtrich, U., Becker, S., et al. (2015) · Breast Cancer Research and Treatment · doi:10.1007/s10549-015-3491-3 · Cited by 113
“However, very recently, another large microarray study (n = 3947) concluded that the prognostic effect of age is based only on differences in subtype composition [20].”
Background
Metadata
- Authors
- Jenkins, E. O., Deal, A. M., Anders, C. K., Prat, A., Perou, C. M., Carey, L. A., & Muss, H. B.
- Affiliations
- University of North Carolina at Chapel Hill (US)
- Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, North Carolina, USA
- Corresponding author
- Muss, Hyman B.
- Venue
- The Oncologist
- Publisher
- Oxford University Press (OUP)
- Published
- 2014-08-20
- Volume
- 19
- Issue
- 10
- Pages
- 1076-1083
- ISSN
- 1083-7159 (ISSN-L)
- 1549-490X
- PMC
- PMC4200998
- OpenAlex
- W2136746515
- Cited by
- 165
- References
- 42
- Citations by year
- 2026: 11 · 2025: 16 · 2024: 16 · 2023: 17 · 2022: 17 · 2021: 11 · 2020: 19 · 2019: 15 · 2018: 10 · 2017: 14 · 2016: 9 · 2015: 9 · 2014: 1
- FWCI
- 3.53
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- academic.oup.com/journals/pages/open_access/funder_policies/chorus/standard_publication_model (vor)
- Locations
- The Oncologist (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Breast Cancer Research Foundation
- NCI SPORE in Breast Cancer (CA058223)
- National Cancer Institute (K23CA157728)
- Damon Runyon Cancer Research Foundation Clinical Investigator Award (CI-64-12)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Breast Cancer Treatment Studies
- Health Sciences › Medicine › Pathology and Forensic Medicine › Breast Lesions and Carcinomas
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › BRCA gene mutations in cancer
- Keywords
- breast cancer, PAM50 molecular subtypes, aging, older women, PAM50, luminal A, luminal B, HER2-enriched breast cancer, basal-like, recurrence-free survival, overall survival, disease-specific survival, prognostic factors, age at diagnosis
- MeSH terms
- Adult, Age Factors, Aged, Aged, 80 and over, Breast Neoplasms, Female, Humans, Middle Aged, Receptors, Estrogen, Treatment Outcome, Receptor, ErbB-2, Erb-b2 Receptor Tyrosine Kinases, Gene Expression Profiling, Young Adult, Triple Negative Breast Neoplasms
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.